Osteoartroz kolennogo sustava: sovremennye tendentsii medikamentoznogo lecheniya, rol' selektivnykh ingibitorov iklooksigenazy-2
- Authors: Lyalina V.V1
-
Affiliations:
- Российский государственный медицинский университет, Москва
- Issue: Vol 8, No 8 (2006)
- Pages: 24-28
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/92181
- ID: 92181
Cite item
Full Text
Abstract
За последние несколько лет произошли значительные изменения в области медикаментозного лечения остеоартроза (ОА). Препараты с хондропротективными свойствами, появившиеся относительно недавно, уже стали неотъемлемой частью лечения этого заболевания. В то же время обезболивающие и противовоспалительные препараты, ранее являвшиеся основным методом лечения, не утратили своего значения.
Keywords
Full Text
##article.viewOnOriginalSite##References
- Голубев Г.Ш., Кригштейн О.С. Оценка доказательств эффективности средств, претендующих называться структурно - модифицирующими препаратами. Междун. журн. мед. практики,2005,2:38-52.
- Мареев В.Ю. Кардиологический пациент и сопутствующая патология. Еще раз о кардиологической безопасности НПВП. Опубликовано www.OSSN.ru по материалам симпозиума Конгресса "Человек и Лекарство", 2005 г.
- Насонов Е.Л. Нестероидные противовоспалительные препараты (перспективы применения в медицине). М., "Анко", 2000.
- Насонов Е.Л., Чичасова Н.В., Ковалёв В.Ю. Глюкокортикоиды в ревматологии. М.,1998.
- Условия и требования к внутрисуставному и периартикулярному введению глюкокортикостероидных препаратов. Методические указания 2001/25 Министерства Здравоохранения РФ, М.,2001.
- Чичасова Н.В. Лечение остеоартроза. Влияние на хрящевую ткань различных противовоспалительных препаратов. Рус. Мед. журн. 2005;13 (8): 539-43.
- Arroll B, Goodyear-Smith F. "Corticosteroid injections for osteoarthritis of the knee: meta - analysis". BMJ, 2004, 328:869.
- Ayral X. Injections in the treatment of osteoarthritis. Best Pract Res Clin Rheumatol, 2001; 15: 609-26.
- Blot L, Marcelis A, Devogelaer J.P, Manicourt D.H. Effects of diclofenac, aceclofenac and meloxicam on the metabolism of proteoglycans and hyaluronan in osteoarthritic human cartilage. Br J Pharmacology, 2000, 131, 1413-21.
- Brandt K.D. The role of analgesics in the management of osteoarthritis pain. Am J Ther, 2000,7,75-90.
- Bruyere O, Compere S, Rovati L.C et al. Five - year follow up of patients from a previous 3-year randomized, controlled trial of Glucosamine sulfate in Knee Osteoarthritis. Arthr Rheum, 2003; 48(s):A89.
- Carrabba M, Paresce E et al. The safety and efficacy of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion. Eur J Rheumatol Inflamm, 1995, 15:25-31.
- Corrado E.M, Peluso G.F, Gigliotti S et al. The effects of intraarticular administration of hyaluronic acid on osteoarthritis of the knee: a clinical study with immunological and biochemical evaluations. Eur J Rheumatol Inflamm, 1995;15:47-56.
- Creamer P. Intraarticular corticosteroid treatment in osteoarthritis. Curr Opin Rheumatol., 1999, 11(5), 417-21.
- Dieppe P.A, Francel S.J, Toht B. Is research into the treatment of osteoarthritis with NSAIDs misdirected? Lancet, 1993, 341, 353-4.
- Dingle J.T. The effect of nonsteoridal anti - inflammatory drugs on human articular cartilage glycosaminoglycan synthesis. Osteoarthritis and cartilage, 1999,7, 313-14.
- Dougados M, Nguyen M, Listrat V, Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo controlled trial. Osteoarthritis Cartilage, 1993, 1, 97-103.
- Gimbel J, Brugger A, Zhao W et al. Efficacy and tolerability of Celecoxib versus Hydrocodone/Acetaminophen in treatment of pain after ambulatory orthopedic surgery in adults. Clinic Therapeuti, 2201,V23,(#2), 228-41.
- Goldstein J.L, Eisen G.M, Lewis B. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol 2005;3,133-41.
- Graham D.J, Campen D.H, Hui R et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo - oxygenase 2 selective and non - selective non - steroidal anti - inflammatory drugs: nested case - control study. Lancet. 2005;365:475-81.
- Gray R, Tenenbaum J et al. Local corticosteroid injection treatment in rheumatic disorders. Sem Arthr Rheum, 1981; 10, 231-54.
- Huskisson E.C, Donelly S. Hyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology (Oxford), 1999; 38:602-7.
- Ike R.W. Therapeutic Injections of the joints and soft tissues, In: Primer on Rheumatic Diseases, 11th ed. Klippel J.H. The Arthritis Foundation. Atlanta.1997.
- Jansen T.L, Roon E.N Four cases of secondary Cushingoid state following local triamcinolone acetonide injection Neth J Med,2002,60:151-3.
- Johnson A.G, Nguyen T.V et al. Do nonsteroidal anti - inflammatory drugs affect blood pressure? A meta - analysis. Ann Intern Med, 1994,121,289-300.
- Jordan K.M, Arden N.K, Doherty M et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis,2003,62,1145-1155.
- Kauser H, Kley H. Cortisontherapie: Corticoid in Klinik und Praxis. Thieme, Stutgart, New York, 1997.
- Laporte J-R, Ibanez L et al. Upper gastrointestinal bleeding associated with the use of NSAIDs. Newer versus older agents. Drug Safety 2004; 27(6):411-420.
- Leeb B, Schweitzer H et al. A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis. J Rheumatol, 2000, 27, 205-211.
- Listrat V, Ayral X et al. Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis cartilage, 1997, 5, 153-60.
- Lussier A, Cividino A.A et al. Viscosupplementation with Hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. J Rheumatology, 1996, 23, 1579-85.
- Mamdami M, Juurlink D.N, Lee D.S et al. Cyclo - oxygenase-2 inhibitors vs non - selective nonsteroidal antiinflammatory drugs and congestive heart failure outcomes in elderly patients. A population - based cohort study. Lancet, 2004, 363,1751-6.
- Mastbergen S.C, Lafeber F.P et al. Selective COX-2 inhibition prevents proinflammatory cytokine - induced cartilage damage. Rheumatology 2002,41,801-808.
- Mazieres B, Combe B, et al. Chondroitin sulfate in osteoarthritis of the knee: a prospective double blind placebo - controlled multicenter clinical study. J Rheum, 2001, 28: 173-81.
- Mc Alindon T.E, La Valley M.P et al. Glucosamine and chondroitin for the treatment of osteoarthrosis. A systematic quality assessment and meta - analysis. JAMA, 2000,283, 1469-75.
- Pavelka K, Gatterova J, Olejarova M, et al. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo - controlled, double - blind study. Arch Intern Med, 2002; 162(18):2113-23.
- Pavelka K, Gatterova J, Giacovelli G et al. Glucosamine sulfate prevents total joint replacement in the long term follow up of knee osteoarthritis patients. Arthritis Rheum, 2004; 49(s): A251.
- Pope J.E, Anderson J.J et al. A meta - analysis of the effects of nonsteroidal anti - inflammatory drugs on blood pressure. Arch Intern Med,1993,153, 477-84.
- Raynauld J, Buckland-Wright C, Ward R, Choquette D et al. Safety and efficiency of long - term intraarticular steroid injections in osteoarthritis of the knee. Arthr Rheum, 2003 ;48, 370-7.
- Reginster J.Y, Deroisy R., Rovai L.C, et al. Long term effects of glucosamine sulfate on osteoarthritis progression: a randomized, placebo - controlled clinical trial. Lancet, 2001, 357 (9252): 251-6.
- Reid D, Eastmond C, Rennie J. Hypotalamo - pituitary - adrenal axis suppression after repeated intra - articular steroid injection. Ann Rheum Dis, 1986,45:45-87.
- Simon L.S, Lanza F.L et al. Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacyand safety in two placebo - controlled tials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. Arthritis Rheum. 1998 Sep;41(9):1591-602.
- Simon L.S, Weaver A.L, Graham D.Y et al. Anti - inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA. 1999;282:1921-8.
- Singh G, Triadafilopoulos G. Epidemiology of NSAID induced gastrointestinal complications. The Journal of Rheumatology, 1999, Volume 26, Supp. 56
- Singh G, Lanes S, Triadafilopoulos G. Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with Meloxicam. The American Journale of Medicine, 2004, 100-6.
- Singh G, Fort J.G, Goldstein J.L et al. for the SUCCESS-I Investigators. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I study. Am J Med. 2006;119:255-66.
- Todhunter R, Fubini S, Wooton J, Lust G. Effect of methylprednisolon acetate on proteoglycan and collagen metabolism of articular cartilage explants. J Rheumatol, 1996, 23,1207-13.
- Towheed T.E, Maxwell L, Anastassiades T.P, Shea B et al. Glucosamine therapy for treating osteoarthritis. The Cochrane Database reviews 2005, Issue 2.
- Tramer M.R, Moore R.A, Reynolds D.J.M, Mc Quay H.J. Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use. Pain. 2000;169-82.
- van Tuyl S.A.C, Slee P.H. Are the effects of local treatment with glucocorticoids only local? The Netherl. J. Med., 2202; 60, (3),130.
- Uelelhard D, Thonar E.J et al. Effect of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study. Osteoarthritis cartilage, 1998, 6(suppl F): 49-56.
- Wobig M, Bach G, Beks P et al. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hyalan G-F 20 and a lower molecular weight hyaluronan. Clin Ther, 1999; 21:1549-62.